Merck Serono Income Statement
View: Annual | Quarterly
| Dec 05 | Dec 04 | Dec 03 | |
|---|---|---|---|
| Revenue | 2,586.4 | 2,458.1 | 2,018.6 |
| Cost of Goods Sold | 265.9 | 304.1 | 279.6 |
| Gross Profit | 2,320.5 | 2,153.9 | 1,739.0 |
| Gross Profit Margin | 89.7% | 87.6% | 86.1% |
| SG&A Expense | 2,404.2 | 1,480.3 | 1,168.5 |
| Depreciation & Amortization | 136.9 | 145.2 | 135.6 |
| Operating Income | (220.6) | 528.4 | 434.9 |
| Operating Margin | -- | 21.5% | 21.5% |
| Nonoperating Income | 76.9 | 67.3 | 41.4 |
| Nonoperating Expenses | 16.9 | -- | 13.0 |
| Income Before Taxes | (160.5) | 595.7 | 462.7 |
| Income Taxes | 52.0 | 123.1 | 64.7 |
| Net Income After Taxes | (212.5) | 472.7 | 398.0 |
| Continuing Operations | (213.3) | 471.0 | 398.4 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (213.3) | 471.0 | 398.4 |
| Total Net Income | (213.3) | 471.0 | 398.4 |
| Net Profit Margin | -- | 19.2% | 19.7% |
| Diluted EPS from Total Net Income ($) | -- | -- | -- |
| Dividends per Share | -- | -- | -- |





